Observational Study of Vision Improvement in Patients With Retinal Disorders
- Conditions
- Age-related Macular DegenerationDiabetic Macular Edema
- Interventions
- Device: Corneal treatment by a low vision aid device
- Registration Number
- NCT04693702
- Lead Sponsor
- Optimal Acuity Corporation
- Brief Summary
The purpose of this study is to assess the vision improvement achieved by patients with retinal disorders who received corneal treatments by a low vision aid device.
- Detailed Description
The purpose of this study is to assess the vision improvement achieved by patients with retinal disorders, including age-related macular degeneration and diabetic macular edema, who received corneal treatments by a low vision aid device. Patient records will be analyzed to determine measures of vision improvement including best spectacle-corrected distance visual acuity (CDVA). Analyses will include descriptive statistics and correlation between outcomes and baseline characteristics.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 54
-
- Female or male
-
- Any race
-
- Patient is at least 50 years old
-
- Patient has diagnosed retinal disorder that causes central vision loss in one or both eyes
-
- Treated eyes, at time of treatment, were pseudophakic or phakic with no significant vision loss due to cataract
-
- Patient had moderate to severe baseline vision impairment with CDVA of 20/63 or worse (decimal = 0.317 or less; logMAR greater than or equal to 0.50) in the treated eye(s)
-
- Patient CDVA records are available at baseline and at 1m or longer post-Tx times
1 - Corneal disease or disorder in either eye 2 - Increased intraocular pressure (above 20mm Hg), glaucoma or history of glaucoma 3 - Presence or history of any other condition or finding that, in the opinion of the investigator, makes the patient unsuitable for retrospective observational study
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Age-related Macular Degeneration Corneal treatment by a low vision aid device - Diabetic Macular Edema Corneal treatment by a low vision aid device -
- Primary Outcome Measures
Name Time Method CDVA 12 months Best spectacle-corrected distance visual acuity
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Bochner Eye Institute
🇨🇦Toronto, Ontario, Canada